These results suggested that WD-specific iPSC-derived hepatocytes expressed either or both decreased levels of ATP7B protein and/or its mislocalization, which might be regulated at the posttranscriptional level, depending on the type of ATP7B mutation involved. Here, ATP7B is linked to Wilson disease.